These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30255820)

  • 1. Detecting responses to treatment with fenofibrate in pedigrees.
    Cherlin S; Wang MH; Bickeböller H; Cantor RM
    BMC Genet; 2018 Sep; 19(Suppl 1):64. PubMed ID: 30255820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of parent-of-origin effects induced by fenofibrate treatment on triglycerides levels.
    Sarnowski C; Lent S; Dupuis J
    BMC Genet; 2018 Sep; 19(Suppl 1):83. PubMed ID: 30255771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification effect of fenofibrate therapy, a longitudinal epigenomic-wide methylation study of triglycerides levels in the GOLDN study.
    Wei R; Wu Y
    BMC Genet; 2018 Sep; 19(Suppl 1):75. PubMed ID: 30255776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate.
    Aslibekyan S; Goodarzi MO; Frazier-Wood AC; Yan X; Irvin MR; Kim E; Tiwari HK; Guo X; Straka RJ; Taylor KD; Tsai MY; Hopkins PN; Korenman SG; Borecki IB; Chen YD; Ordovas JM; Rotter JI; Arnett DK
    PLoS One; 2012; 7(10):e48663. PubMed ID: 23119086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control for Illumina 450K methylation data in the absence of iDat files using correlation structure in pedigrees and repeated measures.
    LeBlanc M; Nustad HE; Zucknick M; Page CM
    BMC Genet; 2018 Sep; 19(Suppl 1):66. PubMed ID: 30255766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics, heritability and longitudinal analysis.
    Nustad HE; Almeida M; Canty AJ; LeBlanc M; Page CM; Melton PE
    BMC Genet; 2018 Sep; 19(Suppl 1):77. PubMed ID: 30255778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies.
    Irvin MR; Rotroff DM; Aslibekyan S; Zhi D; Hidalgo B; Motsinger-Reif A; Marvel S; Srinivasasainagendra V; Claas SA; Buse JB; Straka RJ; Ordovas JM; Borecki IB; Guo X; Chen IY; Rotter JI; Wagner MJ; Arnett DK
    Pharmacogenet Genomics; 2016 Jul; 26(7):324-33. PubMed ID: 27002377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
    Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
    Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.
    Wojczynski MK; Gao G; Borecki I; Hopkins PN; Parnell L; Lai CQ; Ordovas JM; Chung BH; Arnett DK
    J Lipid Res; 2010 Nov; 51(11):3316-23. PubMed ID: 20724655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of detecting genotype-by-methylation interaction: GAW20.
    de Andrade M; Warwick Daw E; Kraja AT; Fisher V; Wang L; Hu K; Li J; Romanescu R; Veenstra J; Sun R; Weng H; Zhou W
    BMC Genet; 2018 Sep; 19(Suppl 1):81. PubMed ID: 30255819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.
    Irvin MR; Kabagambe EK; Tiwari HK; Parnell LD; Straka RJ; Tsai M; Ordovas JM; Arnett DK
    Circ Cardiovasc Genet; 2010 Oct; 3(5):462-7. PubMed ID: 20729559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating methylation genome information improves prediction accuracy for drug treatment responses.
    Xia X; Weng H; Men R; Sun R; Zee BCY; Chong KC; Wang MH
    BMC Genet; 2018 Sep; 19(Suppl 1):78. PubMed ID: 30255773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment.
    Smith JA; Arnett DK; Kelly RJ; Ordovas JM; Sun YV; Hopkins PN; Hixson JE; Straka RJ; Peacock JM; Kardia SL
    Eur J Hum Genet; 2008 May; 16(5):603-13. PubMed ID: 18212815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN).
    Wojczynski MK; Parnell LD; Pollin TI; Lai CQ; Feitosa MF; O'Connell JR; Frazier-Wood AC; Gibson Q; Aslibekyan S; Ryan KA; Province MA; Tiwari HK; Ordovas JM; Shuldiner AR; Arnett DK; Borecki IB
    Metabolism; 2015 Oct; 64(10):1359-71. PubMed ID: 26256467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.
    Yusuf N; Hidalgo B; Irvin MR; Sha J; Zhi D; Tiwari HK; Absher D; Arnett DK; Aslibekyan SW
    Pharmacogenomics; 2017 Sep; 18(14):1333-1341. PubMed ID: 28835163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care.
    Muñoz MA; Liu W; Delaney JA; Brown E; Mugavero MJ; Mathews WC; Napravnik S; Willig JH; Eron JJ; Hunt PW; Kahn JO; Saag MS; Kitahata MM; Crane HM
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):254-60. PubMed ID: 23892238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants.
    Dong Y; Steffen BT; Cao J; Tsai AK; Ordovas J; Straka R; Zhou X; Kabagambe E; Hanson NQ; Arnett D; Tsai MY
    Atherosclerosis; 2011 Feb; 214(2):422-5. PubMed ID: 21159339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study.
    Irvin MR; Aslibekyan S; Do A; Zhi D; Hidalgo B; Claas SA; Srinivasasainagendra V; Horvath S; Tiwari HK; Absher DM; Arnett DK
    Clin Epigenetics; 2018; 10():56. PubMed ID: 29713391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of novel and existing methods for detecting differentially methylated regions.
    Lent S; Xu H; Wang L; Wang Z; Sarnowski C; Hivert MF; Dupuis J
    BMC Genet; 2018 Sep; 19(Suppl 1):84. PubMed ID: 30255775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.